Return to Vaccination News Home Page  __»   Right-click to "open in new window"

Subscribe to the Vaccination NewsLetter

View past & current Scandals (columns by Sandy Mintz)

Search This Site using keywords

http://query.nytimes.com/gst/abstract.html?res=F10F14F6385F0C768EDDAF0894DB404482

National Desk | June 25, 2003, Wednesday
Study Finds New Risks in Hormone Therapy

By DENISE GRADY (NYT) 1626 words
Late Edition - Final , Section A , Page 1 , Column 2

ABSTRACT - Further analysis of data from Women's Health Initiative reveals that combination estrogen plus progestin hormone therapy not only stimulates growth of breast cancer, as reported in July 2002, but also makes tumors harder to detect, leading to dangerous delays in diagnosis; women taking combination therapy are also more likely to have changes in their breast tissue that lead to abnormal mammograms, problems that can show up as soon as first year of hormone use; study raises questions about safety of even short-term use of combination therapy, and Wyeth, maker of Prempro, most popular brand, says it should be taken for shortest duration of time at lowest dose; editorial in Journal of American Medical Assn, where study is published, say it provides further compelling evidence against use of combination therapy; more than half of six million women who were taking combination therapy in July 2002 have since given it up; second study finds that women who take estrogen only, without progestin, have no increased risk of breast cancer, even if they take hormone for 25 years or more; estrogen alone can cause cancer of uterus and is prescribed only for women who have had hysterectomies (M) One year after a major study linked postmenopausal hormone therapy to an increased risk of breast cancer, new findings from the same study paint an even more ominous picture of the hormones' role in the disease.

In addition to stimulating the growth of breast cancer, the combination of hormones used in a common type of therapy also makes tumors harder to detect, leading to dangerous delays in diagnosis, researchers are reporting today in The Journal of the American Medical Association.



 

PURCHASING FROM NYTIMES.COM IS QUICK AND SECURE.
To read the complete article, simply click on one of the BUY NOW buttons below.

You can buy this single article or, for even greater value, you can purchase this article as part of a multi-pack. You'll then have the opportunity to buy additional articles now or in the future at significant savings!

 
Purchase Single Article -- $2.95  
Purchase as part of Article 4-Pack -- $7.95
($1.99/article - a 33% savings!)
Pack expires after 1 month
 
 
Purchase as part of Article 10-Pack -- $15.95
($1.60/ article - a 46% savings!)
Pack expires after 3 months
 
 
Purchase as part of Article 25-Pack -- $25.95
($1.05/ article - a 65% savings!)
Pack expires after 6 months
 
 

How multi-packs work: A multi-pack is an archive package that saves you money by allowing you to pre-purchase a set number of articles in bulk at a reduced price. You can then debit from your multi-pack and quickly access articles from the archive at your convenience over the lifetime of the multi-pack.

Once you purchase an article, you may view it as often as you like over the next 90 days. Archive articles do not include photos, charts or graphics

Click here to purchase article if you already own an archive article pack.


Copyright 2003 The New York Times Company | Privacy Information

Return to Vaccination News Home Page  __»   Right-click to "open in new window"

DISCLAIMER:    All information, data, and material contained, presented, or provided here is for general information purposes only and is not to be construed as reflecting the knowledge or opinions of the publisher, and is not to be construed or intended as providing medical or legal advice.  The decision whether or not to vaccinate is an important and complex issue and should be made by you, and you alone, in consultation with your health care provider.